Drug Shortage Active
PRECEDEX is currently in shortage. Reason: Available. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
PRECEDEX (dexmedetomidine hydrochloride) by Pfizer is 2 -adrenergic agonist with sedative properties. First approved in 1999.
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
PRECEDEX (dexmedetomidine hydrochloride) is an alpha-2 adrenergic agonist administered by intravenous injection that provides sedation and anxiolysis in clinical settings. It selectively binds alpha-2 receptors at therapeutic doses, with dual alpha-1/alpha-2 activity observed only at high doses or rapid infusion. The drug is used for sedation in intensive care and perioperative settings where patient awareness and rapid reversibility are clinically important.
PRECEDEX remains in peak commercial stage with stable market presence, supporting established brand management and field-based teams.
2 -adrenergic agonist with sedative properties. Alpha 2 selectivity is observed in animals following slow intravenous infusion of low and medium doses (10–300 mcg/kg). Both alpha 1 and alpha 2 activity is observed following slow intravenous infusion of high doses (≥1,000 mcg/kg) or with rapid…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
A Study to Learn About the Study Medicine - Precedex in Children From Japan.
Precedex Special Investigation (in Pediatric Patients)
Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
Worked on PRECEDEX at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moPRECEDEX offers stable career opportunities within an established product portfolio, particularly suited for professionals seeking experience in specialty hospital-based pharmaceuticals and ICU medicine. With no active clinical development and current supply constraints, roles focus on commercial execution and supply chain optimization rather than innovation or trial management.